Researcher
Jeroen MEBIS
- Keywords:Medicine
- Disciplines:Cancer biology, Cancer diagnosis, Cancer prevention, Cancer therapy, Oncology not elsewhere classified
Affiliations
- Cardio & organ systems (Department)
Member
From1 Jan 2020 → Today - Cardio & organ systems (Research group)
Member
From1 Jan 2020 → Today - Limburg Clinical Research Center (Research Center)
Member
From1 Jan 2020 → Today - Faculty of Medicine and Life Sciences (Faculty)
Member
From1 Sep 2012 → Today - Physiology - Biochemistry - Immunology (Department)
Member
From1 Sep 2012 → 31 Dec 2019 - Immunology - Biochemistry (Research group)
Member
From1 Sep 2012 → 31 Dec 2019
Projects
1 - 10 of 10
- Plasma-treated hydrogels as a new selective therapy for head and neck cancerFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- PHotobiomodulation therapy for the management of cancEr therapy-reLated comPlications - HELPFrom1 Sep 2021 → TodayFunding: Nonprofit institution or equivalents
- Photobiomodulation therapy for the management of cancer therapy-related side effectsFrom1 Sep 2021 → TodayFunding: Nonprofit institution or equivalents
- NEED - Bioresponsive nanocarriers as a therapy for cancer and wound healing.From1 Jan 2021 → TodayFunding: BOF - projects
- An integrated digital PROM-platform for cancer patients during the COVID-19 pandemicFrom22 Jun 2020 → 21 Dec 2020Funding: Nonprofit institution or equivalents
- Dental stem cells as effective vehicles in a new therapy for oral squamous cell carcinoma.From1 Jan 2020 → 31 Dec 2023Funding: FWO research project (including WEAVE projects)
- Photobiomodulation therapy for the prevention and management of chemotherapy-induced side effectsFrom1 Aug 2019 → 31 Dec 2023Funding: Nonprofit institution or equivalents
- Credit for participation at a congress abroad at MASCC/ISOO 2019 Annual Meeting San Francisco USA 21-23/06/2019From21 Jun 2019 → 23 Jun 2019Funding: International Cooperation and Mobility
- Photobiomodulation therapy for the prevention and management of radiodermatitis in cancer patientsFrom1 Oct 2017 → 30 Sep 2021Funding: Nonprofit institution or equivalents
- Postoperative radiotherapy in stage III non-small cell lung cancer: Is a reassessment necessary in modern times?From1 Aug 2015 → 31 Jul 2016Funding: BOF - Doctoral projects
Publications
1 - 10 of 63
- A novel, multi-active emollient for the prevention of acute radiation dermatitis in breast cancer patients: a randomized clinical trial(2023)
Authors: Jolien ROBIJNS, Leen Van Bever, Sanne Hermans, Marithe CLAES, Joy LODEWIJCKX, Melissa Lenaerts, Laura Tuts, Eline Vandaele, Evelien Vinken, Leen Noé, et al.
- GeNeo: Agnostic comprehensive genomic profiling versus limited panel organ-directed next-generation sequencing within the Belgian PRECISION initiative(2023)
Authors: P. G. Aftimos, K. Punie, L. Decoster, C. Van Marcke de Lummen, A. Hebrant, G. Raicevic, E. Van Valckenborgh, Brigitte MAES, J. Maetens, J. J. Collignon, et al.
Pages: S253 - S254 - The use of photobiomodulation therapy for the management of chemotherapy-induced alopecia: a randomized, controlled trial (HAIRLASER trial)(2023)
Authors: Joy LODEWIJCKX, Jolien ROBIJNS, Marithe CLAES, Maud Pierson, Melissa Lenaerts, Jeroen MEBIS
- Steroid-dependent pericarditis following anti-PD1 immunotherapy in a metastatic melanoma patient: a case report(2023)
Authors: Marthe Verhaert, Jeroen MEBIS, Sandrine Aspeslagh, Berlinde von Kemp, Valentina Rossi, Roman Komorovsky, Alessia Gambaro, Boldizsar Kovacs, Marta Peverelli, Nikesh Jathanna
Pages: 1 - 5 - Efficacy of olaparib in advanced cancers with germline or somatic tumor mutations in BRCA1, BRCA2, CHEK2 and ATM: A Belgian precision tumor-agnostic phase II study(2023)
Authors: S. R. Joris, H. Denys, J. J. Collignon, M. Rasschaert, D. T'Kint de Roodenbeke, F. P. Duhoux, J-L. Canon, S. Tejpar, Jeroen MEBIS, L. Decoster, et al.
Pages: S242 - Evaluation of a novel skin care product for the management of chemotherapy– related dermatologic toxicities: A quasi-experimental study(2023)
Authors: Jolien ROBIJNS, Joy LODEWIJCKX, Marithe CLAES, Laura Tuts, Melissa Lenaerts, Tim Wessels, Annelies Requilé, Daisy Luyten, Jolanda Verheezen, Eric Joosens, et al.
- Photobiomodulation in the management of chemotherapy-induced peripheral neuropathy: a randomized, controlled trial(2023)
Authors: Marithe CLAES, Joy LODEWIJCKX, S. Hermans, P. Peeters, Jeroen MEBIS, Jolien ROBIJNS
Pages: 97 - 119 - Afatinib for EGFR, HER2 or HER3 mutated solid tumors: A phase II Belgian precision study(2023)
Authors: L. Decoster, P. G. Aftimos, S. Rottey, H. Prenen, J. J. Collignon, Jeroen MEBIS, J-L. Canon, V. Fastenaekels, N. Cappoen, S. R. Joris, et al.
Pages: S262 - Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer: a study of the Belgian and Luxembourg Gynaecological Oncology Group(2022)
Authors: I Vergote, E Van Nieuwenhuysen, S De Waele, C Vulsteke, C Lamot, H Van den Bulck, Nele CLAES, MP Graas, Guy DEBROCK, I Spoormans, et al.
Pages: 753 - 760 - The perspective of patients on the use of telemedicine in cardiovascular care(2022)
Authors: L. Knaepen, H. Essarti, Y. Vervoort, K. Driesen, Jeroen MEBIS, F. Vandenberk, A. Vanoppen, Paul DENDALE, Lien DESTEGHE, Hein HEIDBUCHEL
Pages: 4